Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Profiling mTOR pathway in neuroendocrine tumors.

Targeted oncology - 1 Sept 2012

Cingarlini S, Bonomi M, Corbo V, Scarpa A, Tortora G

Abstract excerpt

The serine/threonine kinase mammalian target of rapamycin (mTOR) plays a central role in regulating critical cellular processes such as growth, proliferation, and protein synthesis. The study of cancer predisposing syndromes within which neuroendocrine tumors (NETs) may arise has furnished clues on the involvement of mTOR pathway in sporadic diseases so far. Recent comprehensive analyses have definitely shown...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNAs
Share to Neovascularization, Pathologic
Share to Neuroendocrine Tumors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Phosphatidylinositol 3-Kinases

Share to PTEN Phosphohydrolase

Share to TOR Serine-Threonine Kinases

Share to Tuberous Sclerosis Complex 2 Protein

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 22890559
DOI: 10.1007/s11523-012-0226-9

Genes

PTEN
TSC2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Profiling mTOR pathway in neuroendocrine tumors.PMID 22890559Read ↗

mTOR Signaling in Metabolism and CancerSemantic proximity Read ↗

mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR nodeSemantic proximity Read ↗

mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex ModelSemantic proximity Read ↗

The mTOR Signaling Pathway in Pediatric NeuroblastomaSemantic proximity Read ↗

mTOR signalling: jack-of-all-tradesSemantic proximity Read ↗

mTOR signaling-related MicroRNAs and Cancer involvementSemantic proximity Read ↗

PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic DiseasesSemantic proximity Read ↗

mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disordersSemantic proximity Read ↗

An expanding role for mTOR in cancer.Semantic proximity Read ↗

ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancerSemantic proximity Read ↗

Molecular neurobiology of mTORSemantic proximity Read ↗

Dysregulation of the TSC-mTOR pathway in human diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.